| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.047 | 0.3 |